Skip to Main Content

Paper Details

Evaluation of the effect of necitumumab on the corrected QT interval in patients with advanced solid tumors.
Cancer Chemother Pharmacol
3
2016
Necitumumab, Patients, advanced solid tumors, epidermal growth factor receptor, human, human immunoglobulin G1 monoclonal antibody, necitumumab, patients
Author NameAffiliation
David C SmithUniversity of Michigan, 1500 E Medical Center Drive SPC 5913 ann arbor
Raffael Kurek
Raffael Kurek
  • 1 - 3

Datasets

Release 1.2